Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-02 Sale | 2024-01-04 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,952 | $31.01 | $308,637 | 3,715,048 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 5:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,000 | $28.54 | $342,480 | 3,725,000 (Direct) | View |
| 2023-11-20 Sale | 2023-11-22 2:31 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 19,700 | $28.8 | $567,315 | 131,800 (Direct) | View |
| 2023-10-25 Sale | 2023-10-27 6:23 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 24,338 | $24.21 | $589,223 | 3,737,000 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 5:51 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,550 | $26.33 | $40,812 | 21,734 (Direct) | View |
| 2023-09-18 Sale | 2023-09-20 6:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $28.12 | $1,624,223 | 4,170,563 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 8,925 | $35.31 | $315,142 | 61,575 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 6:15 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 3,000 | $35.53 | $106,590 | 188,484 (Direct) | View |
| 2023-06-27 Sale | 2023-06-29 6:41 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 15,000 | $36.2 | $543,000 | 381,704 (Direct) | View |
| 2023-05-05 Sale | 2023-05-08 6:29 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 6,500 | $40.9 | $265,850 | 143,135 (Indirect Direct) | View |
| 2023-05-03 Sale | 2023-05-05 7:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $39.32 | $4,125,674 | 4,745,298 (Direct) | View |
| 2023-03-03 Sale | 2023-03-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 11,350 | $32.65 | $370,578 | 7,867 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:14 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 875 | $32.62 | $28,542 | 149,635 (Indirect Direct) | View |
| 2023-01-09 Sale | 2023-01-11 8:23 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 3,200 | $30 | $96,000 | 41,410 (Direct) | View |
| 2023-01-05 Sale | 2023-01-06 7:30 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 15,000 | $37.39 | $560,850 | 413,375 (Direct) | View |
| 2023-01-05 Sale | 2023-01-06 7:24 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 13,803 | $37.4 | $516,232 | 191,484 (Direct) | View |
| 2023-01-03 Sale | 2023-01-05 7:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 17,500 | $38.33 | $670,802 | 428,375 (Direct) | View |
| 2023-01-03 Sale | 2023-01-05 7:05 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 10,338 | $38.38 | $396,738 | 205,287 (Direct) | View |
| 2022-12-29 Sale | 2022-12-30 5:12 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 30,625 | $40 | $1,225,000 | 336,704 (Direct) | View |
| 2022-11-21 Sale | 2022-11-22 6:05 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 19,500 | $29.99 | $584,738 | 91,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-15 Option Award | 2023-12-19 4:03 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 14,987 | $25.41 | 65,825 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:55 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 14,987 | $25.41 | 114,754 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:54 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 14,987 | $25.41 | 22,854 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:52 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 14,987 | $25.41 | 36,721 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:51 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 14,987 | $25.41 | 132,622 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:41 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 14,987 | $25.41 | 51,804 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $4.75 | 4,170,563 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | 2013-10-01 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,555 | $0 | 4,170,563 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $2.01 | 4,745,298 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | 2013-06-01 2023-05-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $0 | 4,745,298 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-12 3:23 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 12,460 | $0 | 55,431 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:38 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 12,460 | $0 | 35,860 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:35 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 12,460 | $0 | 27,877 (Direct) | View |
| 2023-01-10 Disposition | 2023-01-11 8:35 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,764 | $0 | 27,877 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:32 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 12,460 | $0 | 104,360 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:27 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 12,460 | $0 | 128,728 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:23 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 12,460 | $0 | 41,410 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:17 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 12,460 | $0 | 23,810 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:21 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 500 | $0 | 70,500 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:18 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 60,000 | $0 | 151,500 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:14 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 60,000 | $0 | 396,704 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 65,000 | $0 | 428,375 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:05 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 60,000 | $0 | 205,287 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 8:01 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 32,000 | $6.15 | 380,875 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 8:01 pm | 2016-02-01 2026-01-01 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 32,000 | $0 | 380,875 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 7:09 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 252,400 | $0 | 3,720,714 (Direct) | View |
| 2022-06-15 Ownership | 2022-09-30 5:32 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 96,676 | $0 | 367,329 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 5:15 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 1,542 | $31.21 | 3,468,314 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 5:15 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 39,082 | $30.77 | 3,468,314 (Direct) | View |
| 2022-07-08 Disposition | 2022-07-12 7:39 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 551,197 | $0 | 3,508,938 (Direct) | View |